August 19, 2019
It was volatile last week; who says it’s about to change?
Warning “shots” have been fired; proceed cautiously; don’t get “sucked-in”
RMi outlines the preludes of a new week defining the mitigating factors of share pricing - I’d be taking money ‘off the table” in reference to some upsides
August 19, 2019
Share pricing is down -$0.01 to $0.98
Pricing of $57.5 M offering of preferred stock and warrants and entry into concurrent Private Placement of up to $70 MM and $12.1 M "Upfront Option Fee"
... SELL
August 16, 2019
As only 4 out of the 39 upside (of 45 covered) had higher than the 3 month average volume;
Pre-open indication: “I have been dipping my “toe” into some sector equities. An addendum”, another bounce down is due; I’d be watching the upsiders for being deflated.
The sector is what it is, until it isn’t and even then it doesn’t seem to be…
August 5, 2019
A scorecard of earnings of 45 covered companies The current LPS (loss per share) or net income, cash positions i.e. "runways" - is a reflection of this universe's investing "status"
August 5, 2019
Volatility, algorithms, sustainability … but, geopolitical ssues are "trumping" the news Add to the list, trend analysis, momentum’s magnitude, technicals and fundamentals – do they indicate expected pricing performance in 2019? Why spend time finding sector news and analytics … it’s all right here! News has become "something" sold into
May 19, 2019
A scorecard of earnings of 45 covered companies 41 so far: 2 acquired (AST, OSIR) 1 on acquisition hold - ONCE) and 1 set to be reversed (HSGX) ... The current LPS (loss per share) or net income, cash positions i.e. "runways" - is a reflection of this universe's investing "status"
The process of calling out our grading of covered companies to rank and review the facts in evidence together with analysis, opinion and objective recommendation.
© 2019 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
